temozolomide has been researched along with Adenohypophyseal Diseases in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pre-temozolomide treatment, these data were 5." | 1.91 | Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain. ( Araujo-Castro, M; Biagetti, B; Cámara, R; Fajardo, C; García-Centeno, R; Guerrero-Pérez, F; Hanzu, F; Iglesias, P; Lamas, C; Mora, M; Remon-Ruiz, P; Soto, A, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lamas, C | 1 |
| Cámara, R | 1 |
| Fajardo, C | 1 |
| Remon-Ruiz, P | 1 |
| Biagetti, B | 1 |
| Guerrero-Pérez, F | 1 |
| Araujo-Castro, M | 1 |
| Mora, M | 1 |
| Hanzu, F | 1 |
| Iglesias, P | 1 |
| García-Centeno, R | 1 |
| Soto, A | 1 |
1 other study available for temozolomide and Adenohypophyseal Diseases
| Article | Year |
|---|---|
Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain.
Topics: Female; Humans; Male; Neuroendocrine Tumors; Pituitary Diseases; Pituitary Neoplasms; Retrospective | 2023 |